Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
8.56
-0.56 (-6.20%)
Market open: Aug 12, 2026, 11:02 AM EDT
9.00
-0.12 (-1.34%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company’s technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
| Name | Position |
|---|---|
| Dr. Robert Schwartz M.D. | Co-Founder & Chief Medical Officer |
| Mr. Bradley Hauser | CEO & President |
| Mr. David A. Robins | Co-Founder & Independent Director |
| Mr. Landy Toth | Co-Founder & Chief Technology Officer |
| Mr. Trent N. Smith CPA | Chief Financial Officer |
| Mr. Walter V. Klemp | Executive Chairman |
| Ms. Jennifer Cook | Chief Business Officer |
| Ms. Lori H. Bisson | Executive Vice Chairman |
| Date | Type | Document |
|---|---|---|
| 2026-07-28 | S-3 | amix20260721_s3.htm |
| 2026-07-15 | 8-K | amix20260714c_8k.htm |
| 2026-07-10 | 8-K | amix20260709_8k.htm |
| 2026-06-24 | 8-K | amix20260619_8k.htm |
| 2026-06-15 | 10-K/A | amix20260331c_10ka.htm |
| 2026-05-27 | 10-K | amix20260331_10k.htm |
| 2026-04-02 | S-8 | amix20260326_s8.htm |
| 2026-02-11 | 10-Q | amix20251231_10q.htm |
| 2026-01-16 | 8-K | amix20260114_8k.htm |
| 2026-01-09 | 8-K | amix20260108_8k.htm |